title: Femorofemoral bypass for aortofemoral graft limb occlusion: a ten-year experience.
abstract: OBJECTIVE
  Aortofemoral bypass (AFB) is a durable reconstruction; however, graft limb occlusion occurs in 10% to 20% of patients and results in limb ischemia. Treatment of AFB limb occlusion has been debated, but many recommended femorofemoral bypass (FFB). FFB grafts have had excellent patency rates. The durability of FFB specifically for AFB limb occlusion has not been reported. This study retrospectively examined a 10-year experience with FFB for AFB limb occlusion to determine FFB performance.
  
  
  METHODS
  Between 1982 and 1992, FFB was performed on occluded AFB limbs in 22 patients (14 men and 8 women). Reoperation was performed for disabling claudication in five cases, but the remaining 17 patients (77%) had critical limb ischemia. FFB originated from the contralateral patent AFB limb in all cases. Distal anastomosis was to the common femoral artery (n = 8) or the profunda femoris (n = 14). FFB graft patency was confirmed by direct Doppler arterial examination over a mean follow-up of 47 months.
  
  
  RESULTS
  The cumulative life-table primary patency rate of FFB was 54% at 5 years. Reoperative procedures performed in nine cases resulted in a secondary patency rate of 84% at 5 years. The limb salvage rate was also 84% at 5 years, reflecting the impact of successful reoperation. Major amputations (two below-knee, one above-knee) were necessary in only three cases. There were no perioperative deaths after FFB, and the cumulative 5-year survival rate was 77%.
  
  
  CONCLUSIONS
  Aortic graft limb occlusion occurs less frequently than failure of infrainguinal grafts making the success of specific reoperative strategies difficult to document reliably. This study suggests that FFB is a safe and durable alternative for AFB limb failure. An aggressive policy of reoperation has resulted in successful extension of FFB graft function and an excellent rate of limb salvage.
authors.affiliation: Department of Surgery, Northwestern University Medical School, Chicago, Illinois.
authors.forename: K D
authors.initials: KD
authors.lastname: Nolan
authors.forename: M E
authors.initials: ME
authors.lastname: Benjamin
authors.forename: T J
authors.initials: TJ
authors.lastname: Murphy
authors.forename: W H
authors.initials: WH
authors.lastname: Pearce
authors.forename: W J
authors.initials: WJ
authors.lastname: McCarthy
authors.forename: J S
authors.initials: JS
authors.lastname: Yao
authors.forename: W R
authors.initials: WR
authors.lastname: Flinn
mesh_terms: D000368:Aged; D001012:Aorta, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000706:statistics & numerical data; D002641:Chicago / Q000453:epidemiology; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006083:Graft Occlusion, Vascular / Q000453:epidemiology / Q000601:surgery*; D006801:Humans; D007511:Ischemia / Q000601:surgery; D007866:Leg / Q000098:blood supply; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene; D012086:Reoperation / Q000379:methods / Q000706:statistics & numerical data; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene